EZIGNYU Trademark

Trademark Overview


On Wednesday, August 25, 2021, a trademark application was filed for EZIGNYU with the United States Patent and Trademark Office. The USPTO has given the EZIGNYU trademark a serial number of 90902061. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Wednesday, July 17, 2024. This trademark is owned by Eli Lilly and Company. The EZIGNYU trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases
ezignyu

General Information


Serial Number90902061
Word MarkEZIGNYU
Filing DateWednesday, August 25, 2021
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateWednesday, July 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 21, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateWednesday, July 17, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Tuesday, October 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 28, 2021NEW APPLICATION ENTERED
Tuesday, May 17, 2022ASSIGNED TO EXAMINER
Wednesday, May 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 1, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 16, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 21, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 21, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, January 18, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, January 18, 2023SOU EXTENSION 1 FILED
Monday, February 6, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 7, 2023SOU EXTENSION 1 GRANTED
Thursday, July 20, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, February 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, July 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 16, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 16, 2024SOU EXTENSION 3 FILED
Tuesday, January 16, 2024SOU EXTENSION 3 GRANTED
Thursday, January 18, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 16, 2024TEAS EXPRESS ABANDONMENT RECEIVED
Wednesday, July 17, 2024ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Wednesday, July 17, 2024ABANDONMENT - AFTER PUBLICATION
Thursday, July 20, 2023SOU EXTENSION 2 GRANTED
Thursday, July 20, 2023SOU EXTENSION 2 FILED